Bernie Sanders Could Influence FDA Drug-Funding Renewal

The results of the midterm elections could affect negotiations over funding for the Food and Drug Administration, with Sen. Bernie Sanders expected to have a prominent role in shaping the legislation, according to STAT.

The FDA collects fees from pharmaceutical companies to help pay for reviews of their medicines. The Prescription Drug User Fee Act must be renewed before the current law expires on Sept. 30. Without renewal, the FDA’s ability to approve medicines could be disrupted.

Senior Democrats are expected to help shape the legislation, and Sanders, an independent from Vermont, is likely to lead the Senate’s health committee. He is among the lawmakers who have challenged the basic premise of the user-fee system, giving him an opportunity to push for changes during negotiations.

Sources: STAT News.